Padmaja Private Trust Acquires 7.53% Stake in Jeevan Scientific Technology
Padmaja Private Trust has acquired a substantial 7.53% stake in Jeevan Scientific Technology Limited through preferential allotment of 15 lakh equity shares worth Rs 6 crore. The acquisition, completed on January 2, 2026, triggered SEBI disclosure requirements under Regulation 29(1) as the trust crossed the substantial acquisition threshold. This forms part of the company's successful Rs 30.74 crore capital raising initiative, which will fund expansion plans including API/formulation unit acquisitions and working capital requirements.
*this image is generated using AI for illustrative purposes only.
Jeevan Scientific Technology Limited has successfully completed its Rs 30.74 crore capital raising plan through the allotment of convertible warrants and equity shares. The company's board meeting held on January 2, 2026, approved the allotment of securities to promoters and non-promoters following BSE's in-principle approval.
Major Stake Acquisition by Padmaja Private Trust
In a significant development, Padmaja Private Trust has acquired a substantial 7.53% stake in the company through the recent preferential allotment. The acquisition details are as follows:
| Parameter: | Details |
|---|---|
| Acquirer: | Padmaja Private Trust |
| Shares Acquired: | 15.00 lakh |
| Stake Percentage: | 7.53% |
| Investment Value: | Rs 6.00 crore |
| Acquisition Mode: | Preferential Allotment |
| Allotment Date: | January 2, 2026 |
This acquisition triggered disclosure requirements under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as Padmaja Private Trust crossed the substantial acquisition threshold.
SEBI Regulatory Compliance
Following the acquisition, Padmaja Private Trust has filed the mandatory disclosure under Regulation 29(1) of SEBI regulations on January 5, 2026. The filing confirms the acquisition details and provides comprehensive information about the trust's holdings:
| Parameter: | Before Acquisition | After Acquisition |
|---|---|---|
| Trust Holdings: | 0 shares (0%) | 15.00 lakh shares (7.53%) |
| Acquisition Mode: | - | Preferential Allotment |
| Allotment Date: | - | January 2, 2026 |
| Filing Date: | - | January 5, 2026 |
| Promoter Status: | - | Non-Promoter |
Complete Allotment Details
The board has successfully allotted the planned securities as outlined in their earlier proposal:
| Security Type: | Quantity Allotted | Issue Price (Rs) | Amount Raised (Rs Crore) |
|---|---|---|---|
| Convertible Warrants: | 35.00 lakh | 40.00 | 14.00 |
| Equity Shares: | 40.85 lakh | 40.00 | 16.34 |
| Total Fundraising: | 75.85 lakh | 40.00 | 30.34 |
The allotment was completed pursuant to BSE's in-principle approval granted through Letter Reference No. LOD/PREF/HC/FIP/1377/2025-26 dated December 18, 2025.
Updated Capital Structure
Following the allotment, the company's equity capital structure has been revised:
| Parameter: | Before Allotment | After Allotment |
|---|---|---|
| Equity Share Capital: | Rs 15.83 crore | Rs 19.92 crore |
| Number of Shares: | 1.58 crore | 1.99 crore |
| Face Value per Share: | Rs 10.00 | Rs 10.00 |
Fund Utilization and Strategic Plans
The funds raised will be utilized for:
| Purpose: | Allocation (Rs Crore) | Timeline |
|---|---|---|
| Capital Expenditure: | 5.00 | 1 Year |
| Working Capital Requirement: | 3.50 | 1 Year |
| Subsidiary Working Capital & CapEx: | 5.00 | 1 Year |
| Acquisition of API/Formulation Units: | 10.00 | 2 Years |
| General Corporate Purposes: | 7.24 | 1 Year |
This successful capital raise and the entry of Padmaja Private Trust as a substantial investor strengthens Jeevan Scientific Technology's financial position and provides the necessary resources for its planned expansion in the healthcare sector, including potential acquisitions and capacity enhancement initiatives.
Historical Stock Returns for Jeevan Scientific Technology
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.33% | -4.96% | +3.28% | +3.54% | +27.82% | -7.95% |
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
